A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors - Concepedia

Concepedia

Publication | Open Access

A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors

DOI Full Paper Access

320

Citations

53

References

2021

Year

Jia Zhou, Camille Gelot, Constantia Pantelidou, Adam Y. Li, Hatice Yücel, Rachel E. Davis, Anniina Färkkilä, Bose Kochupurakkal, Aleem Syed, Geoffrey I. Shapiro,

Molecular BiologyCancer GeneticsMedicineHomologous-recombination-deficient TumorsNovel TherapyTumor Biology

References

	Year	Citations

Page 1